Trial intelligence / Profile preview

Lidocaine Patch vs Flurbiprofen Patch for Acute Low Back Pain

NCT03171987Phase 4Completed

Sponsor
Taipei Medical University Hospital
Start
Jun 2017
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of lidocaine 10% oropharyngeal spray in acute low back pain (2 arms), sponsored by Taipei Medical University Hospital. Primary endpoint: Numeric Rating Scale at 28 days. Started Jun 2017; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

acute low back pain

Beyond the preview

Go deeper on NCT03171987.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03171987.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call